Effects of Vojta Therapy on the Motor Function of Children With Neuromotor Disorders
Launched by UNIVERSITY OF SALAMANCA · Oct 14, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of Vojta Therapy on improving motor skills in children with neuromotor disorders, specifically those diagnosed with cerebral palsy. Vojta Therapy is a technique used in pediatric rehabilitation that helps children develop better control over their movements, which is important for everyday activities like sitting, crawling, and walking. By focusing on the way the body naturally moves, this therapy aims to enhance the overall motor function of children, potentially leading to better outcomes when combined with other therapies.
To participate in this trial, children aged 0 to 3 years who have been diagnosed with cerebral palsy or another neuromotor disorder may be eligible. However, healthy children or those currently receiving other therapies will not be included in the study. Participants can expect to take part in sessions of Vojta Therapy and will be monitored for any changes in their motor development throughout the trial. This research hopes to provide valuable insights into how Vojta Therapy can benefit children with movement challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female children
- • Diagnosis of cerebral palsy or neuromotor disease
- Exclusion Criteria:
- • healthy subjects
- • Patients receiving other therapy during the procedure
About University Of Salamanca
The University of Salamanca, one of the oldest and most prestigious universities in Spain, is a leading institution in academic research and clinical trials. With a strong commitment to advancing healthcare and medical science, the university engages in innovative research initiatives that address critical health challenges. Its clinical trial programs are characterized by rigorous scientific methodology, interdisciplinary collaboration, and a focus on ethical standards, ensuring high-quality outcomes that contribute to the advancement of medical knowledge and patient care. The University of Salamanca fosters partnerships with healthcare professionals and industry leaders, positioning itself at the forefront of clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported